GENE ONLINE|News &
Opinion
Blog

Protein Degradation Therapeutics
Protein Degradation Therapeutics
Evotec Expands Partnership with Bristol Myers Squibb for Potential $5 Billion Deal
2022-05-11
Protein Degradation Therapeutics
Monte Rosa Bags $95 Million Series C Funding to Advance Protein Degraders
2021-03-14
IL-1R
Kymera Inks US$ 150M Deal with Sanofi for Potential Rheumatoid Arthritis and Eczema Treatments
2020-07-12
Proteasome
Vividion Inks $135 Million Deal with Roche for Targeted Protein Degraders
2020-05-20
LATEST
Parkinson’s Disease Proteins Found to Weaken Blood-Brain Barrier, Study Shows
2026-04-18
Barriers to Immunity Research Identified in Long-Term Care and Retirement Homes Study
2026-04-18
Study Reveals Variability in PD-L1 Combined Positive Score Application Between Clinical Trials and Real-World Settings for Gastroesophageal Cancer
2026-04-18
Study Identifies RIPK1/RIPK3-MLKL Pathway as Target to Reduce Preterm Births
2026-04-18
Low-Temperature Drying and Airtight Packaging Found Effective for Preserving Nutrients in Bauhinia Purpurea Petals
2026-04-18
Study Evaluates Silage Yield and Quality of Maize Genotypes in Türkiye’s Central Black Sea Region Over Multiple Growing Seasons
2026-04-18
Linalool Found to Enhance Tetracycline Effectiveness Against Multidrug-Resistant MRSA
2026-04-18
READ MORE
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
2026-05-11
ASGCT (Gene and Cell Therapy Advances)
Boston, Massachusetts
2026-05-29
ASCO 2026 (Major Oncology Clinical Data)
Chicago, Illinois
2026-06-22
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
2026-06-25
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
SEE MORE
Scroll to Top